Dietary Fiber Mixture in Constipated Pediatric Patients
MIXFIBER
A Controlled, Randomized, Double-blind Trial to Evaluate the Effect of a Dietary Fiber Mixture During Maintenance Treatment and on Colonic Transit Time in Constipated Pediatric Patients
1 other identifier
interventional
54
1 country
1
Brief Summary
The purpose this study was to to evaluate the therapeutic effect of a fibers mixture in the treatment of chronic constipation and on the colonic transit time in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Feb 2008
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 11, 2011
CompletedFirst Posted
Study publicly available on registry
April 12, 2011
CompletedApril 12, 2011
December 1, 2010
11 months
April 11, 2011
April 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical response - Therapeutic success
The primary outcome result measurement was the therapeutic success. This therapeutic success was considered when the patient demonstrated daily evacuations or had interposing days of pasty consistency, without pain or difficulty and the absence of fecal incontinence during the 4 weeks of intervention, without the need of using a laxative or rectal enema.
4 weeks
Secondary Outcomes (1)
Frequent daily evacuations, format and consistency of the feces, total and segmental transit time
4 weeks
Study Arms (2)
Dietary Fiber Mixture
ACTIVE COMPARATORThe dietary fiber mixture was composed of six different types of fibers. It was used for treatment of chronic constipation in children.
Maltodextrine
PLACEBO COMPARATORBlinded control group
Interventions
During the four weeks the patients received fiber mixtures (intervention) or maltodextrine as the placebo. The fiber mixture was composed of six different types of fibers: 10.5% fructooligosaccharides, 12.5% inulin, 24% Arabic gum, 9% resistant starch, 33% Soya polysaccharide e 12% cellulose. The dose was defined in accordance with the child's body weight: 6.3 grams of fiber supplement, which corresponds to 4.8 g of fiber, or placebo(1 table spoon) twice per day, diluted in 200 mL of a milky chocolate drink for children weighing up to 18 kg; 12.6 grams of fiber supplement, which corresponds to 9.6 g of fiber, or placebo (2 table spoons) twice per day, diluted in 200 mL of a milky chocolate drink for children weighing more than 18 Kg.
Eligibility Criteria
You may qualify if:
- Children aged between 4 and 12 years;
- Maintenance treatment using low dose of laxative;
- A family with the socio-economic culture that would make it possible to carry out the procedures of the study's protocol.
You may not qualify if:
- Children with organic cause constipation such as Hirschsprung disease, cerebral paralysis, anorectal and spinal medulla abnormalities and metabolic illnesses;
- The regular use of a fiber supplement during the 4 weeks prior to admission;
- The use of medications that would cause constipation;
- Absence of a fixed or mobile telephone in order to make contact.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Federal University of São Paulolead
- Mauro Batista de Moraiscollaborator
- Soraia Tahancollaborator
- Mauro Sérgio Toporovskicollaborator
- Clarice Blaj Neufeldcollaborator
- Thabata Koester Webercollaborator
Study Sites (1)
UNIFESP - Pediatric Gastroenterology Ambulatory
São Paulo, São Paulo, 04039-031, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 11, 2011
First Posted
April 12, 2011
Study Start
February 1, 2008
Primary Completion
January 1, 2009
Study Completion
December 1, 2010
Last Updated
April 12, 2011
Record last verified: 2010-12